9 citations · 18 across the 13 of their papers we have counts for
4 papers · 2 filters
Design aspects of COVID-19 treatment trials: Improving probability and time of favourable events
Jan Beyersmann, Tim Friede, Claudia Schmoor
As a reaction to the pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a multitude of clinical trials for the treatment of SARS-CoV-2 or the resulting c…
Causal inference methods for small non-randomized studies: Methods and an application in COVID-19
Sarah Friedrich, Tim Friede
The usual development cycles are too slow for the development of vaccines, diagnostics and treatments in pandemics such as the ongoing SARS-CoV-2 pandemic. Given the pressure in su…
Clinical trials impacted by the COVID-19 pandemic: Adaptive designs to the rescue?
Cornelia Ursula Kunz, Silke Jörgens, Frank Bretz +6
Very recently the new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified and the coronavirus disease 2019 (COVID-19) declared a pandemic by the Wo…
Shrinkage estimation for dose-response modeling in phase II trials with multiple schedules
Burak Kürsad Günhan, Paul Meyvisch, Tim Friede
Recently, phase II trials with multiple schedules (frequency of administrations) have become more popular, for instance in the development of treatments for atopic dermatitis. If t…